Nationwide recall of epinephrine injectors could affect HISD students

Are you one of the more than 900 HISD students with a life-threatening allergy to a particular food or substance? If so, and you carry an emergency epinephrine auto-injector, check your device today to make sure it is not the subject of a recent drug recall.

Manufacturer Sanofi US has issued a nationwide recall of all its “Auvi-Q” emergency epinephrine injectors due to potentially inaccurate dosage delivery. The company is voluntarily recalling all Auvi-Q currently on the market (both the 0.15 mg and 0.3 mg strengths), including lot numbers 2299596 through 3037230, which will expire March 2016 through Dec. 2016.

Auvi-Q users are encouraged to contact their healthcare providers immediately for a prescription for an alternate epinephrine auto-injector, and patients should only use their Auvi-Q device if another type is not available. Sanofi US will provide reimbursement for the purchase of new epinephrine auto-injectors.

For complete details, please visit the U.S. Food & Drug Administration website.